Competing with international peers in medical devices

By pairing rigorous quality control with continuous investment into research and development (R&D), Mindray has successfully grown its business beyond its initial patient monitoring systems into more advanced areas such as medical imaging and in vitro diagnostics. We believe this underscores its quality focus. 

Over time, Mindray has been able to expand into premium market segments traditionally dominated by multinationals, while maintaining industry-leading margins through efficient manufacturing and strategic R&D. As a result, Mindray has transformed from a domestic-focused manufacturer into a global medical devices powerhouse, competing with international peers while preserving its cost advantages. The company has grown its global network of customers, with sales to 190 countries and clients that include hospitals in the US as well as established medical institutions in Europe. Despite its growth, which has accelerated in the past five years, the company is only ranked #25 among the world’s medical device companies in terms of sales (2024), which suggests a healthy runway of growth ahead.